From Aspirin to Viagra - Marko, Vladimir
26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
13 °P sammeln
  • Broschiertes Buch

From Aspirin to Viagra, insulin to penicillin, and vaccines to vitamin supplements, drugs have become part of our everyday lives. This staggering global industry wasn't born overnight; advancements in pharmaceutical science have been happening for a long while, over the course of decades and even centuries. This book tells the history of ten prominent substances and how they came to be common household names. It shows how the creation of such influential drugs often began with the right person at the exactly right-or wrong!- time. The chapters tell the stories of geniuses and charlatans;…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
From Aspirin to Viagra, insulin to penicillin, and vaccines to vitamin supplements, drugs have become part of our everyday lives. This staggering global industry wasn't born overnight; advancements in pharmaceutical science have been happening for a long while, over the course of decades and even centuries.
This book tells the history of ten prominent substances and how they came to be common household names. It shows how the creation of such influential drugs often began with the right person at the exactly right-or wrong!- time. The chapters tell the stories of geniuses and charlatans; scholars and amateurs; advances won through hard work or pure luck; and ultimately, the handful of resounding successes that revolutionized a global industry.
Beyond the pioneers of the most famous drugs in our culture, the book analyzes how our perspective on medical treatment has shifted over the decades. Modern standards for testing and administering substances have created a new set of advantages, setbacks, and stigmas, all of which are discussed herein.
Autorenporträt
Vladimir Marko was born in 1952 in Koice, Eastern Slovakia. He studied organic chemistry at Slovak Technical University and biochemistry at Comenius University, both in Bratislava. He finished his university studies in 1975 and PhD. studies in 1980. From 1980 to 1991, Marko worked as a researcher in the Institute of Experimental Pharmacology of the Slovak Academy of Sciences in Bratislava. As a member of the Department of Pharmacokinetics, he was responsible for the determination of drugs in biological fluids. In that time, he published several scientific articles and was also an editor of a book dealing with drug determinations (Determination of Beta-Blockers in Biological Material, Elsevier Science Publishers, 1989). In 1994, Marko began working for the Danish-based pharmacological company Lundbeck, first as a representative and later as the managing director for Slovakia. After nearly 20 years there, he retired in 2013.